Lexington diagnostics maker T2 Biosystems' stock plummets on CEO departure, low earnings
July 31, 2019 at 10:31 AM EDT
Lexington sepsis and lyme disease diagnostics maker T2 Biosystems will soon have a new CEO to lead it through its ongoing financial struggles.
